| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 24172 |
| 1 | ADALIMUMAB | 1616 |
| 2 | PREDNISONE | 1601 |
| 3 | ALBUTEROL SULFATE | 1359 |
| 4 | ERGOCALCIFEROL | 1139 |
| 5 | ACETAMINOPHEN | 1112 |
| 6 | CETIRIZINE HYDROCHLORIDE | 1068 |
| 7 | ASPIRIN | 1065 |
| 8 | ASPIRIN 325 MG | 1054 |
| 9 | ASPIRIN 81 MG | 1054 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TETRAHYDROZOLINE HYDROCHLORIDE | 80 | 0.3019 |
| 1 | ALBENDAZOLE | 128 | 0.0688 |
| 2 | LEBRIKIZUMAB-LBKZ | 78 | 0.0566 |
| 3 | DUPILUMAB | 24172 | 0.0551 |
| 4 | MINERAL OIL | 75 | 0.0540 |
| 5 | PIMECROLIMUS | 84 | 0.0525 |
| 6 | TRALOKINUMAB-LDRM | 284 | 0.0514 |
| 7 | CRISABOROLE | 451 | 0.0476 |
| 8 | PEGFILGRASTIM-BMEZ | 25 | 0.0423 |
| 9 | PYRITHIONE ZINC | 23 | 0.0414 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 24172 |
| 1 | Corticosteroid [EPC] | 4065 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2662 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 2026 |
| 4 | Proton Pump Inhibitor [EPC] | 1499 |
| 5 | Vitamin C [EPC] | 1185 |
| 6 | Benzodiazepine [EPC] | 1144 |
| 7 | Provitamin D2 Compound [EPC] | 1140 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 1115 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 1096 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 24172 | 0.0551 |
| 1 | Interleukin-13 Antagonist [EPC] | 362 | 0.0525 |
| 2 | Anthelmintic [EPC] | 128 | 0.0451 |
| 3 | Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC] | 1 | 0.0357 |
| 4 | Interleukin-31 Receptor alpha Antagonist [EPC] | 262 | 0.0265 |
| 5 | Tubulin Inhibiting Agent [EPC] | 4 | 0.0140 |
| 6 | Aryl Hydrocarbon Receptor Agonist [EPC] | 21 | 0.0125 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 29 | 0.0105 |
| 8 | Interleukin-17 Receptor A Antagonist [EPC] | 20 | 0.0103 |
| 9 | CD3-directed Antibody [EPC] | 5 | 0.0101 |